
GLP-1 Receptor Agonists (GLP-RAs) have transformed the treatment of diabetes and obesity and are an important advance in the successful treatment of these and maybe other chronic diseases. These medicines were originally developed to treat diabetes, with Ozempic, a semaglutide, released in 2016. In 2023 these drugs became known more generally because of their off-target effect of stimulating weight loss (1).
GLP-1 stands for “glucagon-like peptide 1”, a peptide hormone that is released from cells in the small intestine in the presence of nutrients. One of its functions is to mediate the secretion of insulin in response to these nutrients by activating the GLP-1 receptor in the pancreas.
What are some of the off-target effects of GLP-1RAs on aging that researchers are uncovering?
Several research studies of GLP-1 RAs have indicated that not only do they have the positive effects of regulating blood glucose and weight, but they have also shown benefits that include reduction of heart, liver and kidney diseases. A study published in Nature in 2026 by Feng and colleagues (2) now presents evidence that these drugs may even affect aging in a mouse model, attenuating age effects and maintaining cognition. The results are promising. The scientists looked at several recognized hallmarks of aging, including stem cell attrition, inflammation, protein folding and stability issues, and genomic stability. For both hematopoietic stem cells (HSCs) and neural stem cells (NSCs), the authors found that treatment with semaglutide increased the regenerative capacity of the respective tissues. Furthermore, they found that in semaglutide treatment increased expression of mitochondria-related genes and the oxidative-stress response genes, increased ATP content, and reduced levels of reactive oxygen species.
Continue reading “Can GLP-1 RAs Help Me Live Longer? Well…”


We all know that a healthy lifestyle (diet high in whole foods and low in fat, moderate exercise, managing stress and good social support) is good for us. In fact I will go so far as to say that it isn’t even news that these things help our health and well-being. What is news, or at least newly published, is that these changes may also have a positive effect on telomerase activity and telomere length (1). 